GetTopicDetailResponse(id=b0c8659869, topicName=EGFR突變肺癌, introduction=EGFR突變肺癌, content=null, image=null, comments=1, allHits=1679, url=https://h5.medsci.cn/topic?id=6598, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=26197, tagList=[TagDto(tagId=26197, tagName=EGFR突變肺癌)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=886746, encodeId=55bf886e4613, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細(xì)胞肺癌#</a><a href='/topic/show?id=e0e2803e878' target=_blank style='color:#2F92EE;'>#耐藥性#</a><a href='/topic/show?id=b0c8659869' target=_blank style='color:#2F92EE;'>#EGFR突變肺癌#</a>這是基礎(chǔ)研究, objectTitle=Nat Commun：奧希替尼配合耐藥信號(hào)抑制明顯改善EGFR突變型肺癌的預(yù)后, objectType=article, longId=200948, objectId=f9e6200948d3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020919/1600508672351_2467676.PNG, objectUrl=/article/show_article.do?id=f9e6200948d3, replyNumber=0, likeNumber=278, createdTime=2020-09-19, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9e6200948d3, moduleTitle=Nat Commun：奧希替尼配合耐藥信號(hào)抑制明顯改善EGFR突變型肺癌的預(yù)后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f9e6200948d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
